Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 23 min ago
Peer-reviewedCC BY 4.0Polymers

Fluorescent Polymer Platforms in Tumour Mechanobiology and Therapy Monitoring

  1. 1Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310018, China
  2. 2College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou 310027, China
  3. 3Zhejiang Key Laboratory of Intelligent Medical Decision Support, Taizhou Institute of Zhejiang University, Taizhou 318000, China

Abstract

Fluorescent polymer platforms reveal different aspects of tumour mechanobiology, but the strength of the evidence behind their optical readouts varies. This narrative review distinguishes calibrated physical measurements, mechanically active therapies assessed by independent assays, and biochemical or delivery readouts. We classify polymer roles as emission generation, mechanical coupling, chemical gating, and carriage or localisation. Among the selected studies, polymer-assisted molecular rotors measured local microviscosity in mouse CT26 tumours, while fluorescent polyacrylamide inclusions enabled intravital solid-stress inference from calibrated deformation. PEG–gold tethers measured receptor tension in cancer-cell culture. Mechanically responsive fluorophores in synthetic networks remain enabling technologies without tumour validation. Our quantitative comparison covers formulation properties, optical operating conditions, calibration, and demonstrated biological settings, labelling unreported values and inapplicable metrics separately. A cholesterol-modifying polyrotaxane illustrates therapy supported by independent cellular mechanics assays; its fluorescence tracks distribution. Protease, pH, oxygen, and transcript probes provide complementary microenvironment or treatment-response information without directly measuring tissue stiffness. The evidence reviewed here establishes neither a clinically validated polymer-fluorescence biomarker of tumour mechanics nor a universal cross-platform performance ranking. Progress requires a defined physical variable and compartment, maintained formulation integrity, and evidence that the measured change informs a functional treatment outcome.

Related

  1. A dual action coumarin-camptothecin polymer for light responsive drug release and photodynamic therapy
    Paige Shaw, Maxime Klausen, Mark Bradley
    Polymer ChemistryPeer-reviewedCC BYFull text11 citedGeneral biologyGeneral chemistryHAL
  2. Biological and Terahertz-Derived Signatures of Polymer Nanocarrier-Induced Cellular Responses: Toward Structure–Response Relationships in Photodynamic Therapy
    Tiffany Campion, Blandine Lordon, Loïc Alauzet +8
    ACS Applied Bio MaterialsPeer-reviewedCC BY 4.0Full textGeneral biologyMaterials & polymersHAL
  3. Regulatory T cell therapy and immune tolerance in heart transplantation: a translational evidence framework for regulatory T cells-cell characterization and recipient-graft monitoring
    Gong Zhaotong, Liu Yizhang, Li Linke
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0ImmunologyFrontiersCrossref
  4. Integrated multi-omics and machine learning identify core mechanobiology-associated immune genes in pulmonary arterial hypertension
    Pei Wang, Fangchao Zhao, Ting Yang +1
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyCrossrefEurope PMC
  5. Caveolin-1 defines astrocyte mechanobiology in the glial lamina of the optic nerve head.
    Anja K Hoffmann, Anna Dlugosch, Michelle C Geigenfeind +4
    Frontiers in cellular neurosciencePeer-reviewedCC BYFull textCell biologyEurope PMC
BibTeX
@article{chen2026fluorescent,
  title = {{Fluorescent Polymer Platforms in Tumour Mechanobiology and Therapy Monitoring}},
  author = {Xiang Chen and Yujie Li and Jiayi Chen and Wei Liu and Shengsheng Zhao and Mengting Jiang and Jing Yang and Xiaoxiao Fan and Hui Lin},
  journal = {Polymers},
  year = {2026},
  month = oct,
  doi = {10.3390/polym18202578},
  url = {https://www.mdpi.com/2073-4360/18/20/2578},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Fluorescent Polymer Platforms in Tumour Mechanobiology and Therapy Monitoring
AU  - Xiang Chen
AU  - Yujie Li
AU  - Jiayi Chen
AU  - Wei Liu
AU  - Shengsheng Zhao
AU  - Mengting Jiang
AU  - Jing Yang
AU  - Xiaoxiao Fan
AU  - Hui Lin
PY  - 2026
DA  - 2026/10/19
JO  - Polymers
DO  - 10.3390/polym18202578
UR  - https://www.mdpi.com/2073-4360/18/20/2578
AB  - Fluorescent polymer platforms reveal different aspects of tumour mechanobiology, but the strength of the evidence behind their optical readouts varies. This narrative review distinguishes calibrated physical measurements, mechanically active therapies assessed by independent assays, and biochemical or delivery readouts. We classify polymer roles as emission generation, mechanical coupling, chemical gating, and carriage or localisation. Among the selected studies, polymer-assisted molecular rotors measured local microviscosity in mouse CT26 tumours, while fluorescent polyacrylamide inclusions enabled intravital solid-stress inference from calibrated deformation. PEG–gold tethers measured receptor tension in cancer-cell culture. Mechanically responsive fluorophores in synthetic networks remain enabling technologies without tumour validation. Our quantitative comparison covers formulation properties, optical operating conditions, calibration, and demonstrated biological settings, labelling unreported values and inapplicable metrics separately. A cholesterol-modifying polyrotaxane illustrates therapy supported by independent cellular mechanics assays; its fluorescence tracks distribution. Protease, pH, oxygen, and transcript probes provide complementary microenvironment or treatment-response information without directly measuring tissue stiffness. The evidence reviewed here establishes neither a clinically validated polymer-fluorescence biomarker of tumour mechanics nor a universal cross-platform performance ranking. Progress requires a defined physical variable and compartment, maintained formulation integrity, and evidence that the measured change informs a functional treatment outcome.
SN  - 2073-4360
ER  -